Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

Post by ivebeenthereon Jul 17, 2022 11:43am
242 Views
Post# 34829786

Conference call

Conference callIn the question period at the conference call Mister Louis Laflamme said
that there is two questions that the FDA want answers .
The first one refers to Bio compatibility of the product.
To that Mr. Laflamme said that they already made those test
and that their level of confidence was really high that this 
was not going to be a problem.
The second question was about assurance that electricity could
not travel through the savvywire and harm the patient.
Mr. Laflamme said that it was virtually impossible because electricity is
not present in the savvywire only light goes through the optic fiber.
So,to me,its a question of only covering the bases and we will
get FDA approbation in due time.
Again good luck to everyone.

<< Previous
Bullboard Posts
Next >>